DILTIAZEM ER DOSE RESPONSE IN PATIENTS WITH MILD TO MODERATE HYPERTENSION

轻至中度高血压患者的地尔硫卓剂量反应

• 批准号: 3866401
• 负责人: EDWARD C. CONRADI
• 金额: --
• 依托单位: MEDICAL UNIVERSITY OF SOUTH CAROLINA
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3866401
• 关键词: antihypertensive agents; blood pressure; cardiovascular disorder chemotherapy; diltiazem; dosage; drug administration rate /duration; drug adverse effect; human subject; human therapy evaluation; hypertension; placebos

The purpose of this study is to evaluate the blood pressure-lowering effect and safety of different doses of diltiazem-L-maleate, an investigational drug, newly prepared as a once-a-day or extended release tablet compared to placebo in patients with mild to moderate hypertension.

本研究的目的是评价降压作用， 不同剂量马来酸地尔硫卓疗效和安全性 研究药物，新制备的每日一次或缓释 片剂与安慰剂在轻度至中度高血压患者中的比较。